Management of hepatitis B in China

Hepatitis B virus （HBV） infection is a global public health problem. According to the data of WorldHealth Organization （WHO）, 2 billion people worldwide have been infected with HBV, and among them 350400 million are chronic HBV carriers. Hepatitis B causes about 1 million deaths of HBV related liver...

Full description

Saved in:
Bibliographic Details
Published in:Chinese medical journal 2009-01, Vol.122 (1), p.3-4
Main Authors: Lu, Feng-min, Zhuang, Hui
Format: Article
Language:English
Subjects:
Antiviral Agents - therapeutic use
China
HBV
Hepatitis B - drug therapy
Hepatitis B - epidemiology
Hepatitis B - immunology
Hepatitis B - prevention & control
Hepatitis B - therapy
Hepatitis B Vaccines - immunology
Humans
乙型肝炎
乙肝病毒
肝硬变
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatitis B virus （HBV） infection is a global public health problem. According to the data of WorldHealth Organization （WHO）, 2 billion people worldwide have been infected with HBV, and among them 350400 million are chronic HBV carriers. Hepatitis B causes about 1 million deaths of HBV related liver failure, cirrhosis, and hepatocellular carcinoma annually.
ISSN:0366-6999
2542-5641
DOI:10.3760/cma.j.issn.0366-6999.2009.01.001